®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
April 29, 2016
Bloom Burton's analyst Dave Martin discusses Canadian healthcare risks and opportunities on BNN
Bloom Burton’s analyst Dave Martin discusses Canadian healthcare risks and opportunities on BNN
Click on the image to view the full video.
RELATED NEWS
See All News
Registration is now open for the 2025 Bloom Burton & Co. Healthcare Investor Conference!
Bloom Burton & Co. Announces the 2025 Bloom Burton Award
The Globe and Mail | AstraZeneca to invest $820 million in Ontario life science sector, says it will create 700 jobs
Satellos Announces Closing of US$40M Public Offering
The Globe and Mail | Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval
Titan Announces the Closing of Conavi’s Private Placement of Subscription Receipts and Provides Update on the Transaction
Roberto Bellini Receives the 2024 Bloom Burton Award
The Globe and Mail | Ex-Chinook team launches Borealis Biosciences with $150-million from Novartis, Versant
Hamilton City Magazine | Coming to life at McMaster University
Acquisition of Fusion Pharmaceuticals Completed
